Aandeel NUNZ NUNZIA PHARMACEUTICAL COMPANY
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Nunzia Pharmaceutical Company

Aandelen

NUNZ

US67097W1027

Beurs gesloten - OTC Markets
Andere beurzen
 02:10:00 02-12-2023 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,003 USD -.--% Intraday-grafiek van Nunzia Pharmaceutical Company -.--% -.--%
2022 Nunzia Pharmaceutical Company rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2022 CI
2022 Nunzia Pharmaceutical Company rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 30 juni 2022 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Nunzia Pharmaceutical Company Reports Earnings Results for the First Quarter Ended March 31, 2022
NUNZIA PHARMACEUTICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt
Nunzia Pharmaceutical : Annual Report Late filing
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
NUNZIA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020
NUNZIA PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers NUNZ
  4. Nieuws Nunzia Pharmaceutical Company
  5. Andere talen